Search results
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 2 days agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
The Hill· 6 hours agoBoth are sublineages of the JN.1 lineage of the Omicron variant, the main COVID variant for roughly...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoNovavax Reports First Quarter 2024 Financial Results and Operational Highlights PR Newswire GAITHERSBURG, Md., May 10, 2024 Announces co-exclusive licensing agreement with ...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
CBS 47 Fresno· 3 days ago...Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the right to and is developing its own COVID-19-Influenza Combination ...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 2 days agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the...
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 2 days agoThe Stock Advisor service has more than quadrupled the return... has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy....
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks· 2 weeks agoFree Report) closed at $4.33, marking a +0.93% move from the previous day. Shares of the vaccine maker have depreciated by 7.74% over the course of the past month, underperforming ...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 2 days agoThe company, a prominent player in the biotechnology sector focusing on the development of vaccines, reported a net loss of $147.55 million with a loss per share of $1.05.